GlaxoSmithkline Healthcare net up 4.3 pc in Q2

Top Stories

»	RBI cuts repo rate by 25 basis points to 5.25 per cent to spur growth
»	A friend indeed: Putin’s arrival marks geopolitical signal in current global order
»	India aims to lead global green maritime future: Minister
»	Finance Ministry does not issue any direction to LIC on investment of funds: FM Sitharaman
»	Indian rules mandate 'WhatsApp Web' to log out users every six hours

SME Times News Bureau | 08 Nov, 2017
GlaxoSmithkline Consumer Healthcare Ltd on Tuesday reported a Rs 192-crore net profit for the second quarter (Q2) of fiscal 2017-18, registering a marginal 4.3 per cent annual growth from Rs 184 crore in the same period last year.

Sequentially, however, the net profit for Q2 is 46 per cent up from Rs 132 crore posted in the last quarter.

In a regulatory filing on the BSE, the NCR-based company said the revenue from operations at Rs 1,115 crore for Q2 was 6.5 per cent annually lower than Rs 1,193 crore in the like period of last year but up 6.6 per cent sequentially from Rs 1,046 crore in the last quarter.

The blue chip company's scrip of Rs 10 face value lost Rs 43 per share in Tuesday's trading on the BSE to end at Rs 5,466.05 from Monday's closing rate of Rs 5,509.65 and opening price of Rs 5,549.95.